Selecting for Neurogenic Potential as an Alternative for Alzheimer's Disease Drug Discovery

Alzheimer's and Dementia - United States
doi 10.1016/j.jalz.2016.03.016
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Air Pouch Model: An Alternative Method for Cancer Drug Discovery

2019English

Derivatives of Piperazines as Potential Therapeutic Agents for Alzheimer's Disease

Molecular Pharmacology
Molecular MedicinePharmacology
2019English

Drug Development for Alzheimer's Disease: Recent Progress

Experimental Neurobiology
Molecular NeuroscienceNeurologyCellular
2010English

A New Roadmap for Drug Development for Alzheimer's Disease

Nature Reviews Drug Discovery
MedicineDrug DiscoveryPharmacology
2013English

Periodontitis: A Potential Risk Factor for Alzheimer's Disease

BDJ Team
2016English

Traditional Mongolian Medicine – A Potential for Drug Discovery

Scientia Pharmaceutica
Pharmaceutical Science
2008English

Characterization of Human iPSC-derived Astrocytes With Potential for Disease Modeling and Drug Discovery

2019English

Correction: Relative Cerebral Flow From Dynamic PIB Scans as an Alternative for FDG Scans in Alzheimer's Disease PET Studies

PLoS ONE
Multidisciplinary
2019English

Translational Medicine Lessons From Flurizan's Failure in Alzheimer's Disease (AD) Trial: Implication for Future Drug Discovery and Development for AD

Clinical and Translational Science
GeneticsMolecular BiologyPharmacologyBiochemistryNeuroscienceMedicineToxicologyPharmaceutics
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy